Osimertinib patient support. Helping you to navigate and understand your treatment.

This website is only intended for UK patients who have been prescribed TAGRISSO® (osimertinib)

You may be wondering why your doctor prescribed osimertinib?

 

Icon Woman adjuvant
Icon Woman adjuvant

I have early stage
(adjuvant) NSCLC


why osimertinib

Icon Man locally advanced and metastatic
Icon Man locally advanced and metastatic

I have locally advanced
(metastatic) NSCLC


Why osimertinib

What would you like to learn about today?

 

Icon Two ladies - how does osimertinib work
Icon Two ladies - how does osimertinib work

How does
osimertinib work?


Discover

Icon Man and lady sitting I want to understand my lung diagnosis
Icon Man and lady sitting I want to understand my lung diagnosis

I want to understand my
lung cancer diagnosis


Learn more

Icon Lady and Man standing hugging
Icon Lady and Man standing hugging

Where can I go to
get support?


Find help

Icon Lady what happens when I start treatment with osimertinib
Icon Lady what happens when I start treatment with osimertinib

What happens once I start
treatment with osimertinib?


What to expect


GB-73007  I  DOP: January 2026


GB-73008  I  DOP: January 2026

This website is only intended for UK patients who have been prescribed TAGRISSO® (osimertinib), which is indicated after surgery in adults with stage 1B-3A NSCLC with a particular EGFR mutation, and also in locally advanced or metastatic NSCLC with a particular EGFR mutation. It does not replace the Patient Information Leaflet, which you can find in the carton containing your medicine and which you should read alongside this information. If you have any questions about your treatment, talk to your healthcare team or refer to the Patient Information Leaflet.